Streetbeat News

Legal

FOLD

TEVA

Amicus Therapeutics has settled a patent lawsuit with Teva Pharmaceuticals over a generic version of its drug Galafold. The agreement allows Teva to market the generic version in the US starting January 30, 2037, pending FDA approval. The litigation between the two companies will be terminated.

Portfolio Pulse from Vandana Singh

October 17, 2024 | 3:07 pm

GL

Globe Life Inc. reported an extortion attempt involving customer data from its subsidiary, American Income Life Insurance, affecting 5,000 individuals. The company is investigating with no material impact on operations.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 2:36 pm

FOLD

Amicus Therapeutics shares rose following a license agreement with Teva and the resolution of Galafold patent litigation.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 2:09 pm

BNTX

GSK

MRNA

PFE

Northwestern University has filed a patent infringement lawsuit against Moderna, alleging unauthorized use of its lipid nanoparticle technology in Moderna's COVID-19 vaccines. This legal action adds to Moderna's ongoing patent disputes, including a recent lawsuit from GSK. Moderna's stock has seen a slight decline following these developments.

Portfolio Pulse from Vandana Singh

October 17, 2024 | 1:51 pm

BRKR

TXG

The European Unified Patent Court ruled in favor of Bruker and NanoString, invalidating a patent asserted by 10x Genomics against NanoString's CosMx SMI products. This decision follows a similar ruling by the German Federal Patent Court.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:59 pm

CRAK

IEO

PSX

Phillips 66 (NYSE:PSX) faces a $604.9 million jury verdict for misappropriating trade secrets from Propel Fuels. The company plans to cease operations at its Los Angeles refinery by Q4 2025, affecting 900 workers. PSX stock has gained 16% over the past year.

Portfolio Pulse from Nabaparna Bhattacharya

October 17, 2024 | 12:21 pm

PSX

Phillips 66 has been ordered to pay $604.9 million in compensatory damages to Propel Fuels following a lawsuit in the California Superior Court.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 11:11 am

FOLD

TEVA

Amicus Therapeutics has entered a license agreement with Teva, resolving their patent litigation over GALAFOLD. Teva can market a generic version in the US starting January 30, 2037, pending FDA approval. The litigation against Aurobindo continues, while Lupin's case is stayed.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 11:03 am

GOOG

GOOGL

Google has appealed to the 9th Circuit Court to halt a ruling in the Epic v. Google case, which mandates allowing third-party app stores on Google Play. Google argues this poses security risks and impacts its business relationships. The appeal is part of ongoing scrutiny of Google's market power.

Portfolio Pulse from Benzinga Neuro

October 17, 2024 | 9:19 am

GOOG

GOOGL

Ross Gerber, a Tesla investor, warns that Alphabet Inc.'s Google faces an existential threat from AI search tools like ChatGPT and Perplexity AI. This comes amid Google's antitrust battle with the DOJ, which could lead to structural changes in its business.

Portfolio Pulse from Ananya Gairola

October 17, 2024 | 8:38 am